menu
    • menu
    [{"orgOrder":0,"company":"Zhengzhou University","sponsor":"Zhengzhou Children\u2019s Hospital | The First Affiliated Hospital of Zhengzhou University | Women and Children Health Care Center of Luoyang, China | G\u00f6teborg University","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"CHINA","productType":"Protein","year":"2019","type":"Inapplicable","leadProduct":"Evening Primrose Oil","moa":"Erythropoietin receptor","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Phase II","graph3":"Zhengzhou University","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Zhengzhou University \/ Zhengzhou Children\u2019s Hospital | The First Affiliated Hospital of Zhengzhou University | Women and Children Health Care Center of Luoyang, China | G\u00f6teborg University","highestDevelopmentStatusID":"8","companyTruncated":"Zhengzhou University \/ Zhengzhou Children\u2019s Hospital | The First Affiliated Hospital of Zhengzhou University | Women and Children Health Care Center of Luoyang, China | G\u00f6teborg University"},{"orgOrder":0,"company":"UT Southwestern Medical Center","sponsor":"AMAG Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Protein","year":"2014","type":"Inapplicable","leadProduct":"Evening Primrose Oil","moa":"Erythropoietin receptor","graph1":"Hematology","graph2":"Phase I\/ Phase II","graph3":"UT Southwestern Medical Center","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"UT Southwestern Medical Center \/ AMAG Pharmaceuticals","highestDevelopmentStatusID":"7","companyTruncated":"UT Southwestern Medical Center \/ AMAG Pharmaceuticals"}]

    Find Clinical Drug Pipeline Developments & Deals for Evening Primrose Oil

    Menu

    Evening Primrose Oil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Zhengzhou University

                            Country arrow
                            COMPAMED
                            Not Confirmed

                            Zhengzhou University

                            Country arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Evening Primrose Oil

                            Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                            Study Phase : Phase II

                            Sponsor : Zhengzhou Children’s Hospital | The First Affiliated Hospital of Zhengzhou University | Women and Children Health Care Center of Luoyang, China | Göteborg University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis

                            Details : EPO is a Protein drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Premature Birth.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            April 18, 2019

                            Lead Product(s) : Evening Primrose Oil

                            Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                            Highest Development Status : Phase II

                            Sponsor : Zhengzhou Children’s Hospital | The First Affiliated Hospital of Zhengzhou University | Women and Children Health Care Center of Luoyang, China | Göteborg University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            UT Southwestern Medical Center

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            UT Southwestern Medical Center

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Evening Primrose Oil

                            Therapeutic Area : Hematology

                            Study Phase : Phase I/ Phase II

                            Sponsor : AMAG Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

                            Details : EPO is a Protein drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Anemia.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            July 15, 2014

                            Lead Product(s) : Evening Primrose Oil

                            Therapeutic Area : Hematology

                            Highest Development Status : Phase I/ Phase II

                            Sponsor : AMAG Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth